九洲药业: 浙江九洲药业股份有限公司关于2025年半年度利润分配方案的公告

Key Points - The company plans to distribute a cash dividend of 0.20 RMB per share (including tax) to all shareholders, based on the total share capital as of June 30, 2025 [1][2] - The total share capital as of June 30, 2025, is 889,446,028 shares, with a total cash dividend amounting to 176,342,005.60 RMB (including tax) [1][2] - The total amount of cash dividends and share buybacks is 278,333,076.60 RMB, which accounts for 52.93% of the company's net profit attributable to shareholders for the first half of 2025 [2] - The board of directors approved the profit distribution plan during the 16th meeting of the 8th board on August 5, 2025, and it does not require further approval from the shareholders' meeting [2] - The supervisory board agrees that the profit distribution plan complies with relevant laws and regulations and does not harm the interests of shareholders, especially minority shareholders [2]